Quantcast

Latest Biomarker Stories

2014-09-30 08:29:03

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information. The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity ranges from investments and IPOs, to agreements between private proteomic companies and academic institutions, to deals between pharma and biotech companies with novel proteomics innovator companies. Kalorama...

2014-09-26 08:25:19

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental...

2014-09-25 12:27:54

NEW YORK, Sept. 25, 2014 /PRNewswire/ -- The market for "proteomics" instruments, reagents and testing for research and diagnostic applications topped 5 billion dollars in 2013, and should see rapid revenue growth, according to Kalorama information. The healthcare market research publisher said demand for better understanding of proteins and a desire for new therapies is expected to continue to grow the proteomics market rapidly, despite cost pressures generally in research. The...

2014-09-23 23:02:21

OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the theme “Metabolomics Technology and Omics Sciences - A Roadmap for Advanced Research Initiatives” Los Angeles, CA (PRWEB) September 23, 2014 Speaking on this occasion, Dr. Vladimir Bondarenko said “Organizing Committee for Metabolomics-2015 welcomes industrial and academic researchers to attend...

2014-09-23 16:27:31

IRVINE, Calif., Sept. 23, 2014 /PRNewswire/ -- Global Discovery Biosciences, a laboratory dedicated to leveraging research and technology to conquer some of the biggest healthcare challenges, announces their collaboration with IPMD, Inc. to develop a simple and highly accurate blood test for the early detection of lung cancer. Lung cancer is the leading cause of cancer death. Typically, the symptoms and subsequent diagnosis of lung cancer appear at an advanced stage of cancer, where the...

2014-09-19 23:08:36

SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects. Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit...

2014-09-19 23:04:17

GIA announces the release of a comprehensive global report on Immunoassay Systems. Global market for Immunoassay Systems is projected to reach US$17.9 billion by 2020, driven by aging population, rise in chronic & infectious diseases, development of novel biomarkers, robust demand for non-invasive diagnostic tools, and improved access to healthcare & testing services in developing countries. San Jose, California (PRWEB) September 19, 2014 Follow us on LinkedIn – Immunoassays are...

2014-09-19 04:21:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018" [http://www.researchandmarkets.com/research/qqjrnh/global_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand...

2014-09-18 08:29:26

-ATHENA to Shed Light on Rare, Life-Threatening Kidney Disease - LA JOLLA, Calif., Sept. 18, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. The ATHENA study is designed to...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'